Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.16	58.93	59.62
Graham Fair Price	-52.76	13.97	29.57
PEG	-243.71	-0.84	-0.24
Price/Book	-16.15	0.98	1.17
Price/Cash Flow	-160.26	-39.53	-15.19
Prices/Earnings	299.06	65.72	16.47
Price/Sales	-7.09	4.81	5.18
Price/FCF	-160.26	-39.53	-15.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-29.58	0.11	0.16
Operating Margin	-10.67	0.09	0.10
ROA	-78.80	< 0.005	< 0.005
ROE	0.02	< 0.005	-78.99
ROIC	< 0.005	< 0.005	-22.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.04	-49.98
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.71	-0.19	73.97
EPS QOQ	-0.67	-0.78	-16.10
FCF QOQ	-2.53	0.67	-73.35
Revenue QOQ	-0.20	-0.09	55.68
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.07	2.84	-7.66
Days Sales Outstanding (DSO)	39.52	31.03	-21.49
Inventory Turnover	29.29	31.72	8.30
Debt/Capitalization	0.73	0.74	0.52
Quick Ratio	1.39	1.67	20.44
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	46.74	48.17	3.06
Cash	34.19	37.79	10.54
Capex	-5.25	-2.98	43.15
Free Cash Flow	-3.61	-1.20	66.80
Revenue	10.57	9.83	-6.99
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.80	21.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	38.93	40.86	4.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating